nrc.nl
Netherlands Faces IV Bag Shortage
A shortage of IV bags in the Netherlands due to a hurricane-damaged factory is causing concern, prompting government intervention and a review of healthcare policies.
Dutch
Netherlands
HealthNetherlandsHealthcarePolicyEmergencyMedicineShortage
Baxter International Inc.Landelijk Coördinatiecentrum Geneesmiddelen (Lcg)Inspectie Gezondheidszorg En Jeugd (Igj)Erasmus McTreant
Nicole HunfeldNiels GrittersHarmen KrulFleur Agema
- What steps are being taken to address the IV bag shortage?
- The Dutch government is implementing measures to mitigate the shortage, including importing IV bags from other countries, allowing hospitals to share supplies, and advising healthcare workers to conserve IV bags and explore alternative drug delivery methods where possible.
- What is the current impact on patients due to this shortage?
- While the shortage is causing adjustments for healthcare workers, patients are not yet experiencing significant disruptions. The government is monitoring the situation and ensuring that hospitals are working to share and redistribute their IV bag supplies.
- What is the main cause of the IV bag shortage in the Netherlands?
- A shortage of IV bags in the Netherlands is caused by the temporary closure of a Baxter International Inc. factory in North Carolina due to Hurricane Helena. The factory produces 60% of the IV bags used in the Netherlands, leading to a 25% decrease in availability.
- What are the potential solutions being considered to prevent future medicine shortages?
- The Dutch government is exploring ways to improve the situation, such as reviewing the preference policy and considering relocating production to Europe. However, completely abandoning the policy, which contributes to keeping healthcare costs down, is not favored by most.
- What larger issue does the IV bag shortage highlight regarding the Dutch healthcare system?
- The shortage highlights a broader issue of medicine shortages in the Netherlands, often linked to the 'preference policy' where insurers only cover one supplier, leading to vulnerability when that supplier experiences problems. This policy keeps premiums low but leaves the country with limited reserves.